未名医药 (002581.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(未名医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 129,180,025.24133,563,782.4275,602,502.5981,551,446.2287,884,145.56100,257,851.6287,387,093.61
 营业收入(元) 129,180,025.24133,563,782.4275,602,502.5981,551,446.2287,884,145.56100,257,851.6287,387,093.61
二、营业总成本(元) 146,627,573.86179,152,267.81104,535,537.78123,191,584.10148,579,511.79144,974,236.36126,726,567.03
 营业成本(元) 23,878,845.4625,292,519.0114,582,127.6612,025,263.2217,121,905.5019,215,139.1027,849,254.92
 研发费用(元) 9,957,737.5720,416,075.178,327,976.447,641,717.927,744,999.046,770,823.755,131,469.74
 营业税金及附加(元) 1,767,691.362,380,067.58966,548.652,123,295.901,053,238.192,101,555.621,180,959.84
 销售费用(元) 77,053,676.2386,571,136.5749,790,563.5259,057,397.1588,983,431.1683,953,803.2660,483,003.27
 管理费用(元) 31,900,582.2842,132,044.4827,980,380.3040,398,968.5231,525,735.2131,336,548.1730,468,238.37
 财务费用(元) 2,069,040.962,360,425.002,887,941.211,944,941.392,150,202.691,596,366.461,613,640.89
 信用减值损失(元) 62,143.30696,279.55262,988.02-431,712.343,407,457.33-180.001,890,710.04
三、其他经营收益
 加:投资收益(元) 108,016,122.8529,458,014.946,622,813.8212,698,523.2195,030,966.9767,809,807.4141,914,814.10
  其中:对联营企业和合营企业的投资收益(元) -----67,809,807.4141,914,814.10
 资产处置收益(元) -866,505.38-5,973,551.42291,408.4590,781.13---
 其他收益(元) 5,317,536.64428,639.39609,761.884,333,857.40415,226.494,099,006.572,832,907.87
四、营业利润(元) 95,081,748.79-29,310,516.82-21,146,063.02-38,938,716.8538,118,982.8927,192,249.247,298,958.59
 加:营业外收入(元) 31,000.03-16,237.7330,593.43-14,607.244,635.162,376.3640,198.02
 减:营业外支出(元) 1,008,532.10635,774.06339,933.0719,519,030.31719,604.98711,262.3429,521.56
五、利润总额(元) 94,104,216.72-29,962,528.61-21,455,402.66-58,472,354.4037,404,013.0726,483,363.267,309,635.05
 减:所得税费用(元) 4,722,531.37-488,446.43-76,304.0610,459,773.74-1,417,048.772,010,800.802,539,322.00
六、净利润(元) 89,381,685.35-29,474,082.18-21,379,098.60-68,932,128.1438,821,061.8424,472,562.464,770,313.05
(一)按经营持续性分类
  持续经营净利润(元) 89,381,685.35-29,474,082.18-21,379,098.60-68,932,128.1438,821,061.8424,472,562.464,770,313.05
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 83,470,619.53-32,251,312.42-21,505,965.06-79,140,215.1540,493,813.8322,122,045.661,834,525.81
  少数股东损益(元) 5,911,065.822,777,230.24126,866.4610,208,087.01-1,672,751.992,350,516.802,935,787.24
 扣除非经常性损益后的净利润(元) 80,648,883.06-26,043,941.64-22,097,795.75-68,658,309.0341,506,221.4319,244,870.27-590,458.38
七、每股收益
 一、基本每股收益(元) 0.13-0.05-0.03-0.120.060.03-
 二、稀释每股收益(元) 0.13-0.05-0.03-0.120.060.03-
九、综合收益总额(元) 89,381,685.35-29,474,082.18-21,379,098.60-68,932,128.1438,821,061.8424,472,562.464,770,313.05
 归属于母公司所有者的综合收益总额(元) 83,470,619.53-32,251,312.42-21,505,965.06-79,140,215.1540,493,813.8322,122,045.661,834,525.81
 归属于少数股东的综合收益总额(元) 5,911,065.822,777,230.24126,866.4610,208,087.01-1,672,751.992,350,516.802,935,787.24
公告日期 2023-10-312023-08-312023-04-272023-04-272022-10-312022-08-302022-04-30
审计意见(境内) 保留意见

前瞻产业研究院